BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19879425)

  • 1. CLU "in and out": looking for a link.
    Pucci S; Mazzarelli P; Nucci C; Ricci F; Spagnoli LG
    Adv Cancer Res; 2009; 105():93-113. PubMed ID: 19879425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear clusterin accumulation during heat shock response: implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells.
    Caccamo AE; Desenzani S; Belloni L; Borghetti AF; Bettuzzi S
    J Cell Physiol; 2006 Apr; 207(1):208-19. PubMed ID: 16331665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chapter 9: Oxidative stress in malignant progression: The role of Clusterin, a sensitive cellular biosensor of free radicals.
    Trougakos IP; Gonos ES
    Adv Cancer Res; 2009; 104():171-210. PubMed ID: 19878777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chapter 4: Regulation of Clusterin activity by calcium.
    Pajak B; Orzechowski A
    Adv Cancer Res; 2009; 104():33-58. PubMed ID: 19878772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of clusterin/apolipoprotein J on cellular growth and survival.
    Trougakos IP; Lourda M; Agiostratidou G; Kletsas D; Gonos ES
    Free Radic Biol Med; 2005 Feb; 38(4):436-49. PubMed ID: 15649646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IR-inducible clusterin gene expression: a protein with potential roles in ionizing radiation-induced adaptive responses, genomic instability, and bystander effects.
    Klokov D; Criswell T; Leskov KS; Araki S; Mayo L; Boothman DA
    Mutat Res; 2004 Dec; 568(1):97-110. PubMed ID: 15530543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal resistance of fibroblasts against oxidative damage: involvement of tumor cell-secreted platelet-derived growth factor (PDGF) and phosphoinositide 3-kinase (PI3K) activation.
    Werth C; Stuhlmann D; Cat B; Steinbrenner H; Alili L; Sies H; Brenneisen P
    Carcinogenesis; 2008 Feb; 29(2):404-10. PubMed ID: 18174235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation: gearing the journey to cancer.
    Kundu JK; Surh YJ
    Mutat Res; 2008; 659(1-2):15-30. PubMed ID: 18485806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of clusterin (CLU) in malignant transformation and drug resistance in breast carcinomas.
    Redondo M; Tellez T; Roldan MJ
    Adv Cancer Res; 2009; 105():21-43. PubMed ID: 19879421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases.
    Trougakos IP; Gonos ES
    Free Radic Res; 2006 Dec; 40(12):1324-34. PubMed ID: 17090421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CLU and colon cancer. The dual face of CLU: from normal to malignant phenotype.
    Mazzarelli P; Pucci S; Spagnoli LG
    Adv Cancer Res; 2009; 105():45-61. PubMed ID: 19879422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
    Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
    Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
    Keledjian K; Kyprianou N
    J Urol; 2003 Mar; 169(3):1150-6. PubMed ID: 12576871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine and paracrine roles for growth factors in melanoma.
    Shih IM; Herlyn M
    In Vivo; 1994; 8(1):113-23. PubMed ID: 7519892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment--two sides of a coin.
    Capparuccia L; Tamagnone L
    J Cell Sci; 2009 Jun; 122(Pt 11):1723-36. PubMed ID: 19461072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clusterin, a novel modulator of TGF-beta signaling, is involved in Smad2/3 stability.
    Lee KB; Jeon JH; Choi I; Kwon OY; Yu K; You KH
    Biochem Biophys Res Commun; 2008 Feb; 366(4):905-9. PubMed ID: 18082619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin isoforms differentially affect growth and motility of prostate cells: possible implications in prostate tumorigenesis.
    Moretti RM; Montagnani Marelli M; Mai S; Cariboni A; Scaltriti M; Bettuzzi S; Limonta P
    Cancer Res; 2007 Nov; 67(21):10325-33. PubMed ID: 17974975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.